Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-24T04:52:58.075Z Has data issue: false hasContentIssue false
  • English
  • Français

Remission amongst elderly schizophrenia patients

Published online by Cambridge University Press:  15 April 2020

Y. Barak  and
M. Swartz
Y. Barak*
Affiliation:
Abarbanel mental health center, Bat-Yam, 15, KKL street, Bat-Yam, Israel Sackler school of medicine, Tel-Aviv university, Tel-Aviv, Israel
M. Swartz
Affiliation:
Abarbanel mental health center, Bat-Yam, 15, KKL street, Bat-Yam, Israel Sackler school of medicine, Tel-Aviv university, Tel-Aviv, Israel
*
* Corresponding author. Tel.: +972 3 5552738; fax: +972 3 5552738. E-mail address:[email protected] (Y. Barak).
Get access

Abstract

Remission in elderly patients has been little studied. The present analysis utilized a European database to focus on the elderly. Using five different instruments examining remission, we report that aging did not adversely affect remission in the elderly. Management of elderly schizophrenia patients should thus be targeted towards remission.

Keywords

ElderlySchizophreniaRemissionPsychosocial
Type
Short communication
Information
European Psychiatry , Volume 27 , Issue 1 , January 2012 , pp. 62 - 64
Copyright
Copyright © Elsevier Masson SAS 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington DC: American Psychiatric Association; 1994.Google Scholar
Andreasen, NCCarpenter, WTKane, JMLasser, RAMarder, SRWeinberger, DRRemission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441–449CrossRefGoogle ScholarPubMed
Auslander, LAJeste, DVSustained remission of schizophrenia among community-dwelling older outpatients. Am J Psychiatry 2004; 161: 1490–1493CrossRefGoogle ScholarPubMed
Barak, YBleich, AAizenberg, DPsychosocial remission in schizophrenia: developing a clinician-rated scale. Comp Psychiatry 2010; 51: 94–98CrossRefGoogle ScholarPubMed
Bankole, ACohen, CIVahia, IDiwan, SPalekar, NReyes, P, et al.Symptomatic remission in a multiracial urban population of older adults with schizophrenia. Am J Geriatr Psychiatry 2008; 16: 966–973CrossRefGoogle Scholar
Folsom, DPLebowitz, BDLindamer, LAPalmer, BWPatterson, TLJeste, DVSchizophrenia in late life: emerging issues. Dialog Clin Neurosci 2006; 8: 45–52Google ScholarPubMed
Heinrichs, DWHanlon, TECarpenter, WT Jr.The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984; 10: 388–398CrossRefGoogle ScholarPubMed
Helldin, LKane, JMKarilampi, UNorlander, TArcher, TRemission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr Res 2007; 93: 160–168CrossRefGoogle ScholarPubMed
Kay, SRFiszbein, AOpler, LAThe Positive and Negative syndrome Scale for schizophrenia. Schizophr Bull 1987; 13: 261–276CrossRefGoogle Scholar
Llorca, PMLançon, CLancrenon, SBayle, FJCaci, HRouillon, F, et al.The “Functional Remission of General Schizophrenia” (FROGS) scale: development and validation of a new questionnaire. Schizophr Res 2009; 113: 218–225CrossRefGoogle ScholarPubMed
Mausbach, BTHarvey, PDGoldman, SRJeste, DVPatterson, TLDevelopment of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull 2007; 33: 1364–1372CrossRefGoogle ScholarPubMed
Moore, ARO’Keeffe, STDrug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15: 15–28CrossRefGoogle ScholarPubMed
Nasrallah, HMorosini, PGagnon, DDReliability, validity and ability to detect change of the personal and social performance scale in patients with stable schizophrenia. Psychiatry Res 2008; 161: 213–224CrossRefGoogle ScholarPubMed
Pearlson, GDKreger, LRabins, PVChase, GACohen, BWirth, JB, et al.A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry 1989; 146: 1568–1574Google ScholarPubMed
Tadger, SBaruch, YBarak, YSymptomatic remission in elderly schizophrenia patients treated with long-acting risperidone. Int Psychogeriatr 2008; 20: 1245–1250CrossRefGoogle ScholarPubMed
Taylor, DMYoung, CPatel, MXProspective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favorable outcome. Int J Neuropsychopharmacol 2006; 9: 685–694CrossRefGoogle Scholar
van Os, JDrukker, Mà Campo, JMeijer, JBak, MDelespaul, PValidation of remission criteria for schizophrenia. Am J Psychiatry 2006; 163: 2000–2002CrossRefGoogle Scholar
Wiersma, DWanderling, JDragomirecka, EGanev, KHarrison, GAn Der Heiden, W, et al.Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med 2000; 30: 1155–1167CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.